ruthenium tetraoxide has been researched along with betamethasone-17,21-dipropionate in 1 studies
| Studies (ruthenium tetraoxide) | Trials (ruthenium tetraoxide) | Recent Studies (post-2010) (ruthenium tetraoxide) | Studies (betamethasone-17,21-dipropionate) | Trials (betamethasone-17,21-dipropionate) | Recent Studies (post-2010) (betamethasone-17,21-dipropionate) |
|---|---|---|---|---|---|
| 72 | 1 | 25 | 520 | 188 | 220 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuo, KW; Lee, JY; Sheu, HM; Tsai, JC | 1 |
1 other study(ies) available for ruthenium tetraoxide and betamethasone-17,21-dipropionate
| Article | Year |
|---|---|
Permeability barrier abnormality of hairless mouse epidermis after topical corticosteroid: characterization of stratum corneum lipids by ruthenium tetroxide staining and high-performance thin-layer chromatography.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Betamethasone; Chromatography, Thin Layer; Epidermis; Glucocorticoids; Lipids; Male; Mice; Mice, Hairless; Permeability; Ruthenium Compounds | 1998 |